196 related articles for article (PubMed ID: 29279152)
1. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
3. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
Lu J; Pi S; Ma FH; Zhao SH; Li HM; Cai SL; Qiang JW
Eur J Radiol; 2019 Sep; 118():44-50. PubMed ID: 31439257
[TBL] [Abstract][Full Text] [Related]
4. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
[TBL] [Abstract][Full Text] [Related]
5. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
[TBL] [Abstract][Full Text] [Related]
6. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract][Full Text] [Related]
7. Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours.
Han X; Li B; Sun M; Li J; Li Y; Liu A
Clin Radiol; 2021 Aug; 76(8):585-592. PubMed ID: 34059294
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Ma FH; Cai SQ; Li HM; Wang L
Eur Radiol; 2014 Sep; 24(9):2292-9. PubMed ID: 24871335
[TBL] [Abstract][Full Text] [Related]
9. MRI characteristics for differentiating mucinous borderline ovarian tumours from mucinous ovarian cancers.
Yang XY; Li X; Ma FH; Li HM; Zhao SH; Li YA; Qiang JW
Clin Radiol; 2022 Feb; 77(2):142-147. PubMed ID: 34848025
[TBL] [Abstract][Full Text] [Related]
10. MRI appearances of ovarian serous borderline tumor: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Boyko OB; Wang SJ; Cai SQ; Wang L
J Magn Reson Imaging; 2014 Jul; 40(1):151-6. PubMed ID: 24923479
[TBL] [Abstract][Full Text] [Related]
11. MRI for differentiating primary fallopian tube carcinoma from epithelial ovarian cancer.
Ma FH; Cai SQ; Qiang JW; Zhao SH; Zhang GF; Rao YM
J Magn Reson Imaging; 2015 Jul; 42(1):42-7. PubMed ID: 25176611
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
[TBL] [Abstract][Full Text] [Related]
13. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
[TBL] [Abstract][Full Text] [Related]
14. MRI for discriminating metastatic ovarian tumors from primary epithelial ovarian cancers.
Xu Y; Yang J; Zhang Z; Zhang G
J Ovarian Res; 2015 Aug; 8():61. PubMed ID: 26310488
[TBL] [Abstract][Full Text] [Related]
15. Multiple instance convolutional neural network with modality-based attention and contextual multi-instance learning pooling layer for effective differentiation between borderline and malignant epithelial ovarian tumors.
Jian J; Xia W; Zhang R; Zhao X; Zhang J; Wu X; Li Y; Qiang J; Gao X
Artif Intell Med; 2021 Nov; 121():102194. PubMed ID: 34763809
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell tumor of the ovary: computed tomographic and magnetic resonance imaging features with pathological correlation.
Oh SN; Rha SE; Jung SE; Lee YJ; Choi BG; Byun JY; Ku YM; Jung CK
J Comput Assist Tomogr; 2009; 33(1):106-12. PubMed ID: 19188796
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of MRI in the differential diagnosis between benign and malignant ovarian tumors.
Zhang T; Yi X; Lu J; Fu A
Eur J Gynaecol Oncol; 2017; 38(2):257-262. PubMed ID: 29953791
[TBL] [Abstract][Full Text] [Related]
18. Primary ovarian endometrioid adenocarcinoma: magnetic resonance imaging findings including a preliminary observation on diffusion-weighted imaging.
Li HM; Qiang JW; Xia GL; Zhao SH; Ma FH; Cai SQ; Feng F; Fu AY
J Comput Assist Tomogr; 2015; 39(3):401-5. PubMed ID: 25978592
[TBL] [Abstract][Full Text] [Related]
19. The value of MR-detectable ipsilateral ovaries in characterizing the origin and malignancy of an adnexal tumors.
Wang J; Li X; Li HM; Ma FH; Zhang GF; Zhao SH; Qiang JW
Eur J Radiol; 2018 Dec; 109():62-67. PubMed ID: 30527313
[TBL] [Abstract][Full Text] [Related]
20. CT and MRI findings of type I and type II epithelial ovarian cancer.
Liu D; Zhang L; Indima N; Peng K; Li Q; Hua T; Tang G
Eur J Radiol; 2017 May; 90():225-233. PubMed ID: 28583639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
